Systemic Hormonal Contraceptives: Schering goes from strength to strength (Pharmalicencing)
Schering AG , soon to be acquired by fellow German pharma company Bayer , dominates the global market for systemic oral contraceptives (ATC therapy class G3A) with its latest oral contraceptive Yasmin, and should boost its position in the future with the new low-dose version Yaz. Meanwhile Johnson & Johnson , has been adversely affected by safety/side-effect concerns about its Ortho-Evra

Implanon offers new birth control option (WTHR Indianapolis)
Women now have a new option in birth control. Implanon is a new generation hormone implant that has been widely used outside the United States and was just recently FDA-approved. Doctors believe it's both safe and effective.